Cresco Labs Q1 EPS $(0.04), Inline, Sales $165.76M Beat $165.48M Estimate
Author: Benzinga Newsdesk | May 31, 2025 02:32am
Cresco Labs (OTC:
CRLBF) reported quarterly losses of $(0.04) per share which met the analyst consensus estimate. This is a 100 percent decrease over losses of $(0.02) per share from the same period last year. The company reported quarterly sales of $165.76 million which beat the analyst consensus estimate of $165.48 million by 0.17 percent. This is a 10.06 percent decrease over sales of $184.29 million the same period last year.
Posted In: CRLBF